Maia Biotechnology Inc (MAIA) Institutional Holdings & 13F Data (Q2 2026)

MAIA ranks #6956 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

37 institutions disclose a position in MAIA, but none treat it as a major bet — even Solas Capital Management, LLC, its most concentrated holder, allocates just 2.3% of its own portfolio to it.

MAIA reported a net loss of $22.4M in its latest fiscal year.

• Not yet profitable — net loss of $22.4M in the latest fiscal year
• Net income improved year over year, from -$23.3M to -$22.4M
• Operating cash flow was negative, using $18.8M in cash
• Current ratio of 1.66x — enough short-term assets to cover short-term liabilities
• Liabilities run 1897.18x equity — a highly leveraged balance sheet worth noting